CELL RENEWAL AND FUNCTIONAL-MORPHOLOGY OF HUMAN LACTATING BREAST - PRESENTATION OF A NEW MODE OF CELL-DEATH (MAGENTOSIS) CHARACTERIZED BY NUCLEAR PERIODIC ACID-SCHIFF REACTIVITY
S. Umemura et al., CELL RENEWAL AND FUNCTIONAL-MORPHOLOGY OF HUMAN LACTATING BREAST - PRESENTATION OF A NEW MODE OF CELL-DEATH (MAGENTOSIS) CHARACTERIZED BY NUCLEAR PERIODIC ACID-SCHIFF REACTIVITY, Pathology international, 46(2), 1996, pp. 105-121
Cell kinetics and functional morphology of the human lactating breast
were analyzed using 21 paraffin-embedded specimens of the lactating br
east obtained by biopsy or surgery and two of the 'resting' breast. Fo
ur types (I-IV) of lactating lobules were categorized histologically,
and were well correlated with their functional status demonstrated by
immunohistochemistry for epithelial membrane antigen, beta-casein, lip
ase, lactoferrin, secretory component and IgA. Type I corresponded to
a pre-lactating state, type II to an actively lactating state, type II
I to an early stage of regression, and type IV to an advanced stage of
regression, Cell proliferation monitored by Ki-67 (MIB-1) immunostain
ing was at the highest level in type I lobules followed by type IV, wh
ile the labeling indices were low in types II and III. Apoptosis demon
strated by terminal deoxynucleotidyl transferase (TdT)-mediated deoxyu
ridine triphosphate (dUTP)-biotin nick end-labeling (TUNEL) method sho
wed labeling profiles comparable with the proliferative activity. Holo
crine-type desquamative cells with intact-appearing nuclei were freque
ntly recognized in type II lobules, in type III, a peculiar form of ce
ll death, designated 'magentosis', was demonstrated. These degenerativ
e cells occasionally shedding into the acinar lumen possessed homogene
ous pale, TUNEL-negative nuclei with diastase-resistant periodic acid-
Schiff (PAS) reactivity. 'Magentosis' specifically identified in an ea
rly phase of involution of tile human lactating breast might represent
a unique mode of cell death distinguishable from apoptosis and necros
is.